Overview

Ocular Hypertension Treatment Study (OHTS)

Status:
Completed
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
To determine whether medical reduction of intraocular pressure prevents or delays the onset of glaucomatous visual field loss and/or optic disc damage in ocular hypertensive participants judged to be at moderate risk for developing open-angle glaucoma. To produce natural history data to assist in identifying patients at most risk for developing open-angle glaucoma and those most likely to benefit from early medical treatment. To quantify risk factors for developing open-angle glaucoma among ocular hypertensive individuals.
Phase:
Phase 3
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
National Eye Institute (NEI)
Treatments:
Antihypertensive Agents
Ophthalmic Solutions
Tetrahydrozoline